Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Losartan and Vitamin D Inhibit Colonic Tumor Development in a Conditional Apc-Deleted Mouse Model of Sporadic Colon Cancer.

Dougherty U, Mustafi R, Haider HI, Khalil A, Souris JS, Joseph L, Hart J, Konda VJ, Zhang W, Pekow J, Li YC, Bissonnette M.

Cancer Prev Res (Phila). 2019 Jul;12(7):433-448. doi: 10.1158/1940-6207.CAPR-18-0380. Epub 2019 May 14.

PMID:
31088824
2.

Aberrant p53 Immunostaining in Barrett's Esophagus Predicts Neoplastic Progression: Systematic Review and Meta-Analyses.

Snyder P, Dunbar K, Cipher DJ, Souza RF, Spechler SJ, Konda VJA.

Dig Dis Sci. 2019 May;64(5):1089-1097. doi: 10.1007/s10620-019-05586-7. Epub 2019 Mar 26.

PMID:
30911864
3.

Barrett's Esophagus and Esophageal Carcinoma: Can Biomarkers Guide Clinical Practice?

Konda VJA, Souza RF.

Curr Gastroenterol Rep. 2019 Mar 12;21(4):14. doi: 10.1007/s11894-019-0685-6. Review.

PMID:
30868278
4.

Biomarkers of Barrett's Esophagus: From the Laboratory to Clinical Practice.

Konda VJA, Souza RF.

Dig Dis Sci. 2018 Aug;63(8):2070-2080. doi: 10.1007/s10620-018-5088-2. Review.

5.

Endoscopic eradication therapy and the test of time.

Konda VJA, Spechler SJ.

Gastrointest Endosc. 2018 Jan;87(1):85-87. doi: 10.1016/j.gie.2017.07.033. No abstract available.

PMID:
29241865
6.

Perceptions of risk and therapy among patients with Barrett's esophagus: a patient survey study.

Stier MW, Lodhia N, Jacobs J, Nozicka D, Kavitt R, Siddiqui U, Waxman I, Konda VJ.

Dis Esophagus. 2018 Apr 1;31(4). doi: 10.1093/dote/dox109.

PMID:
29036278
7.

Computer-aided diagnosis: further eliminating the human factor in endoscopy?

Konda VJA.

Endoscopy. 2017 Aug;49(8):734-735. doi: 10.1055/s-0043-113439. Epub 2017 Jul 26. No abstract available.

PMID:
28746965
8.

Efficacy, Durability, and Safety of Complete Endoscopic Mucosal Resection of Barrett Esophagus: A Systematic Review and Meta-Analysis.

Tomizawa Y, Konda VJA, Coronel E, Chapman CG, Siddiqui UD.

J Clin Gastroenterol. 2018 Mar;52(3):210-216. doi: 10.1097/MCG.0000000000000800.

PMID:
28134635
9.

Multidisciplinary Approach to Esophageal Achalasia: A Single Center Experience.

Schlottmann F, Andolfi C, Kavitt RT, Konda VJA, Patti MG.

J Laparoendosc Adv Surg Tech A. 2017 Apr;27(4):358-362. doi: 10.1089/lap.2016.0594. Epub 2017 Jan 18.

PMID:
28099056
10.

Risk of infection transmission in curvilinear array echoendoscopes: results of a prospective reprocessing and culture registry.

Chapman CG, Siddiqui UD, Manzano M, Konda VJ, Murillo C, Landon EM, Waxman I.

Gastrointest Endosc. 2017 Feb;85(2):390-397.e1. doi: 10.1016/j.gie.2016.07.049. Epub 2016 Jul 28.

PMID:
27478029
11.

Importance of Esophageal Manometry and pH Monitoring in the Evaluation of Patients with Refractory Gastroesophageal Reflux Disease: A Multicenter Study.

Andolfi C, Bonavina L, Kavitt RT, Konda VJ, Asti E, Patti MG.

J Laparoendosc Adv Surg Tech A. 2016 Jul;26(7):548-50. doi: 10.1089/lap.2016.0189. Epub 2016 May 24.

PMID:
27218861
12.

Post-ablation surveillance in Barrett's esophagus: A review of the literature.

Stier MW, Konda VJ, Hart J, Waxman I.

World J Gastroenterol. 2016 May 7;22(17):4297-306. doi: 10.3748/wjg.v22.i17.4297. Review.

13.

Safety and efficacy of EMR for sporadic, nonampullary duodenal adenomas: a single U.S. center experience (with video).

Singh A, Siddiqui UD, Konda VJ, Whitcomb E, Hart J, Xiao SY, Ruiz MG, Koons A, Waxman I.

Gastrointest Endosc. 2016 Oct;84(4):700-8. doi: 10.1016/j.gie.2016.03.1467. Epub 2016 Apr 8.

PMID:
27063918
14.

Confocal laser endomicroscopy in inflammatory bowel disease: achieving new depths in mucosal healing.

Chapman CG, Konda VJ.

Gastrointest Endosc. 2016 Apr;83(4):792-4. doi: 10.1016/j.gie.2015.11.002. No abstract available.

PMID:
26975284
15.

Barrett's endotherapy: one size still does not fit all.

Waxman I, Konda VJ.

Gastrointest Endosc. 2016 Jan;83(1):78-9. doi: 10.1016/j.gie.2015.06.037. No abstract available.

PMID:
26706298
16.

Colon cancer and the epidermal growth factor receptor: Current treatment paradigms, the importance of diet, and the role of chemoprevention.

Pabla B, Bissonnette M, Konda VJ.

World J Clin Oncol. 2015 Oct 10;6(5):133-41. doi: 10.5306/wjco.v6.i5.133. Review.

17.

Needle-based confocal endomicroscopy for pancreatic cysts: the current agreement in interpretation.

Karia K, Waxman I, Konda VJ, Gress FG, Sethi A, Siddiqui UD, Sharaiha RZ, Kedia P, Jamal-Kabani A, Gaidhane M, Kahaleh M.

Gastrointest Endosc. 2016 May;83(5):924-7. doi: 10.1016/j.gie.2015.08.080. Epub 2015 Sep 14.

PMID:
26382051
18.

Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.

Catenacci DV, Chapman CG, Xu P, Koons A, Konda VJ, Siddiqui UD, Waxman I.

Gastroenterology. 2015 Dec;149(7):1794-1803.e4. doi: 10.1053/j.gastro.2015.08.050. Epub 2015 Sep 2.

19.

Use of probe-based confocal laser endomicroscopy (pCLE) in gastrointestinal applications. A consensus report based on clinical evidence.

Wang KK, Carr-Locke DL, Singh SK, Neumann H, Bertani H, Galmiche JP, Arsenescu RI, Caillol F, Chang KJ, Chaussade S, Coron E, Costamagna G, Dlugosz A, Ian Gan S, Giovannini M, Gress FG, Haluszka O, Ho KY, Kahaleh M, Konda VJ, Prat F, Shah RJ, Sharma P, Slivka A, Wolfsen HC, Zfass A.

United European Gastroenterol J. 2015 Jun;3(3):230-54. doi: 10.1177/2050640614566066. Review. Erratum in: United European Gastroenterol J. 2015 Aug;3(4):404.

20.

Endoscopic imaging.

Konda VJ.

Curr Treat Options Gastroenterol. 2015 Jun;13(2):198-205. doi: 10.1007/s11938-015-0052-0.

PMID:
25783789
21.

Use of narrow-band imaging with magnification to predict depth of invasion of early esophageal squamous cell cancer and to guide endoscopic therapy.

Singh A, Konda VJ, Siddiqui U, Xiao SY, Waxman I.

Gastrointest Endosc. 2015 Feb;81(2):469-70; discussion 470. doi: 10.1016/j.gie.2014.09.058. Epub 2014 Nov 22. No abstract available.

PMID:
25450607
22.

Endoscopy for diagnosis and treatment in esophageal cancers: high-technology assessment.

Akiyama J, Komanduri S, Konda VJ, Mashimo H, Noria S, Triadafilopoulos G.

Ann N Y Acad Sci. 2014 Sep;1325:77-88. doi: 10.1111/nyas.12526.

PMID:
25266017
23.

The renin-angiotensin system mediates EGF receptor-vitamin d receptor cross-talk in colitis-associated colon cancer.

Dougherty U, Mustafi R, Sadiq F, Almoghrabi A, Mustafi D, Kreisheh M, Sundaramurthy S, Liu W, Konda VJ, Pekow J, Khare S, Hart J, Joseph L, Wyrwicz A, Karczmar GS, Li YC, Bissonnette M.

Clin Cancer Res. 2014 Nov 15;20(22):5848-5859. doi: 10.1158/1078-0432.CCR-14-0209. Epub 2014 Sep 11.

24.

Optical biopsy approaches in Barrett's esophagus with next-generation optical coherence tomography.

Konda VJ, Koons A, Siddiqui UD, Xiao SY, Turner JR, Waxman I.

Gastrointest Endosc. 2014 Sep;80(3):516-7. doi: 10.1016/j.gie.2014.07.022. No abstract available.

PMID:
25127947
25.

A single-center experience of endoscopic submucosal dissection performed in a Western setting.

Lang GD, Konda VJ, Siddiqui UD, Koons A, Waxman I.

Dig Dis Sci. 2015 Feb;60(2):531-6. doi: 10.1007/s10620-014-3260-x. Epub 2014 Aug 5.

PMID:
25092035
26.

The not so NICE classification.

Singh A, Konda VJ, Siddiqui UD.

Gastrointest Endosc. 2014 Jun;79(6):1030-1. doi: 10.1016/j.gie.2014.01.025. No abstract available.

PMID:
24856845
27.

Complete endoscopic mucosal resection is effective and durable treatment for Barrett's-associated neoplasia.

Konda VJ, Gonzalez Haba Ruiz M, Koons A, Hart J, Xiao SY, Siddiqui UD, Ferguson MK, Posner M, Patti MG, Waxman I.

Clin Gastroenterol Hepatol. 2014 Dec;12(12):2002-10.e1-2. doi: 10.1016/j.cgh.2014.04.010. Epub 2014 Apr 13.

PMID:
24732285
28.

Early diagnosis and management of esophageal and gastric cancer.

Lang GD, Konda VJ.

Minerva Gastroenterol Dietol. 2013 Dec;59(4):357-76. Review.

PMID:
24212354
29.

A pilot study of in vivo identification of pancreatic cystic neoplasms with needle-based confocal laser endomicroscopy under endosonographic guidance.

Konda VJ, Meining A, Jamil LH, Giovannini M, Hwang JH, Wallace MB, Chang KJ, Siddiqui UD, Hart J, Lo SK, Saunders MD, Aslanian HR, Wroblewski K, Waxman I.

Endoscopy. 2013 Dec;45(12):1006-13. doi: 10.1055/s-0033-1344714. Epub 2013 Oct 25.

PMID:
24163192
30.

Nanoscale markers of esophageal field carcinogenesis: potential implications for esophageal cancer screening.

Konda VJ, Cherkezyan L, Subramanian H, Wroblewski K, Damania D, Becker V, Gonzalez MH, Koons A, Goldberg M, Ferguson MK, Waxman I, Roy HK, Backman V.

Endoscopy. 2013 Dec;45(12):983-8. doi: 10.1055/s-0033-1344617. Epub 2013 Sep 9.

31.

Is Endoscopic Ultrasound (EUS) necessary in the pre-therapeutic assessment of Barrett's esophagus with early neoplasia?

Fernández-Sordo JO, Konda VJ, Chennat J, Madrigal-Hoyos E, Posner MC, Ferguson MK, Waxman I.

J Gastrointest Oncol. 2012 Dec;3(4):314-21. doi: 10.3978/j.issn.2078-6891.2012.038.

32.

Development of subsquamous cancer after hybrid endoscopic therapy for intramucosal Barrett's cancer.

Konda VJ, Gonzalez Haba Ruiz M, Hart J, Waxman I.

Endoscopy. 2012;44 Suppl 2 UCTN:E390-1. doi: 10.1055/s-0032-1310139. Epub 2012 Nov 8. No abstract available.

PMID:
23139036
33.

Evaluation of microvascular density in Barrett's associated neoplasia.

Konda VJ, Hart J, Lin S, Tretiakova M, Gordon IO, Campbell L, Kulkarni A, Bissonnette M, Seewald S, Waxman I.

Mod Pathol. 2013 Jan;26(1):125-30. doi: 10.1038/modpathol.2012.146. Epub 2012 Aug 24.

34.

Endotherapy for Barrett's esophagus.

Konda VJ, Waxman I.

Am J Gastroenterol. 2012 Jun;107(6):827-33. doi: 10.1038/ajg.2012.70. Review.

PMID:
22488078
35.

Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions.

Konda VJ, Dalal K.

Ther Clin Risk Manag. 2011;7:447-58. doi: 10.2147/TCRM.S23425. Epub 2011 Nov 22.

36.

American ginseng suppresses Western diet-promoted tumorigenesis in model of inflammation-associated colon cancer: role of EGFR.

Dougherty U, Mustafi R, Wang Y, Musch MW, Wang CZ, Konda VJ, Kulkarni A, Hart J, Dawson G, Kim KE, Yuan CS, Chang EB, Bissonnette M.

BMC Complement Altern Med. 2011 Nov 9;11:111. doi: 10.1186/1472-6882-11-111.

37.

First assessment of needle-based confocal laser endomicroscopy during EUS-FNA procedures of the pancreas (with videos).

Konda VJ, Aslanian HR, Wallace MB, Siddiqui UD, Hart J, Waxman I.

Gastrointest Endosc. 2011 Nov;74(5):1049-60. doi: 10.1016/j.gie.2011.07.018. Epub 2011 Sep 15.

PMID:
21924718
38.

Biliary confocal laser endomicroscopy real-time detection of cholangiocarcinoma.

Chennat J, Konda VJ, Madrigal-Hoyos E, Fernandez-Sordo J, Xiao SY, Hart J, Waxman I.

Dig Dis Sci. 2011 Dec;56(12):3701-6. doi: 10.1007/s10620-011-1795-7. Epub 2011 Jun 22. No abstract available.

PMID:
21695400
39.

Low risk of prevalent submucosal invasive cancer among patients undergoing esophagectomy for treatment of Barrett's esophagus with high grade dysplasia.

Konda VJ, Waxman I.

J Gastrointest Oncol. 2011 Mar;2(1):1-4. doi: 10.3978/j.issn.2078-6891.2011.005. No abstract available.

40.

Endotherapy for Barrett's esophagus: Which, how, when, and who?

Chennat J, Konda VJ, Waxman I.

Gastrointest Endosc Clin N Am. 2011 Jan;21(1):119-33. doi: 10.1016/j.giec.2010.09.001. Review.

PMID:
21112502
41.

Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how?

Konda VJ, Ferguson MK.

World J Gastroenterol. 2010 Aug 14;16(30):3786-92. Review.

42.

Confocal laser endomicroscopy: potential in the management of Barrett's esophagus.

Konda VJ, Chennat JS, Hart J, Waxman I.

Dis Esophagus. 2010 Jul;23(5):E21-31. doi: 10.1111/j.1442-2050.2010.01088.x. Epub 2010 Jul 8.

PMID:
20626448
43.

Endoscopic techniques for recognizing neoplasia in Barrett's esophagus: which should the clinician use?

Waxman I, Konda VJ.

Curr Opin Gastroenterol. 2010 Jul;26(4):352-60. doi: 10.1097/MOG.0b013e32833ad5c4. Review.

PMID:
20571387
44.

Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.

Chennat J, Konda VJ, Ross AS, de Tejada AH, Noffsinger A, Hart J, Lin S, Ferguson MK, Posner MC, Waxman I.

Am J Gastroenterol. 2009 Nov;104(11):2684-92. doi: 10.1038/ajg.2009.465. Epub 2009 Aug 18.

PMID:
19690526
45.

Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.

Chennat J, Ross AS, Konda VJ, Lin S, Noffsinger A, Hart J, Waxman I.

Gastrointest Endosc. 2009 Sep;70(3):417-21. doi: 10.1016/j.gie.2009.01.047. Epub 2009 Jun 24.

PMID:
19555948
46.

Mucosal ablation of Barrett esophagus.

Waxman I, Konda VJ.

Nat Rev Gastroenterol Hepatol. 2009 Jul;6(7):393-401. doi: 10.1038/nrgastro.2009.90. Epub 2009 Jun 2. Review. Erratum in: Nat Rev Gastroenterol Hepatol. 2010 Apr;7(4):182.

PMID:
19488071
47.

Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated?

Konda VJ, Ross AS, Ferguson MK, Hart JA, Lin S, Naylor K, Noffsinger A, Posner MC, Dye C, Cislo B, Stearns L, Waxman I.

Clin Gastroenterol Hepatol. 2008 Feb;6(2):159-64. Epub 2007 Dec 21.

PMID:
18096439

Supplemental Content

Loading ...
Support Center